Evidence map›Paper›PMID 37852594›Full record

ArticleTravel medicine and infectious disease

Infections with long latency in international refugees, immigrants, and migrants seen at GeoSentinel sites, 2016-2018.

Elizabeth D Barnett, Alyse B Wheelock, William B MacLeod, Anne E McCarthy, Patricia F Walker, Christina M Coyle, Christina A Greenaway, Francesco Castelli, Rogelio López-Vélez, Federico G Gobbi and 6 more

Open access · goldAbstract read
In one paragraph

Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Chagas Disease in Europe.Tropical medicine and infectious disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 6 countries.

Elizabeth D BarnettDepartment of Pediatrics, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Alyse B WheelockSection of Preventive Medicine and Epidemiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Electronic address: Alyse.wheelock@bmc.org.
William B MacLeodDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Anne E McCarthyDepartment of Medicine, University of Ottawa, Ottawa, Canada.
Patricia F WalkerDepartment of Medicine, University of Minnesota, HealthPartners Institute, Minnesota, USA.
Christina M CoyleDepartment of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY, USA.
Christina A GreenawaySMBD Jewish General Hospital, Division of Infectious Diseases, McGill University, Montreal, Quebec, Canada.
Francesco CastelliUniversity Division of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, Brescia, Lombardy, Italy.
Rogelio López-VélezRamón y Cajal Institute for Health Research, Ramón y Cajal University Hospital, Madrid, Spain.
Federico G GobbiDepartment of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Elena TrigoDepartment of Internal Medicine, National Referral Unit for Imported Tropical Diseases, High Level Isolation Unit, Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, Spain.
Martin P GrobuschCenter of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Philippe GautretVITROME, Aix Marseille University, IRD, AP-HM, SSA, Marseille, France; Institut Méditerranée Infection, Marseille, France.
Davidson H HamerDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Susan KuhnDepartment of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
William M StaufferDepartment of Medicine, University of Minnesota, Minnesota, USA.
Boston University · USUniversity of Minnesota · USAix-Marseille Université · FRAlbert Einstein College of Medicine · USAmsterdam University Medical Centers · NLHospital Universitario La Paz · ESInstituto Cajal · ESJewish General Hospital · CAOspedale Sacro Cuore Don Calabria · ITUniversity of Brescia · ITUniversity of Calgary · CAUniversity of Ottawa · CA

Funding

Multidisciplinary Training Program in Cardiovascular EpidemiologyT32HL125232 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Matthew G. Nayor, Vanessa Xanthakis · 2016 to 2026
$5.0M
NCEZID CDC HHS U01 CK000632NCEZID CDC HHS U50 CK000189NHLBI NIH HHS T32 HL125232
6 · The paper itself

Abstract

backgroundThe continued increase in global migration compels clinicians to be aware of specific health problems faced by refugees, immigrants, and migrants (RIM). This analysis aimed to characterize RIM evaluated at GeoSentinel sites, their migration history, and infectious diseases detected through screening and diagnostic workups.

methodsA case report form was used to collect data on demographics, migration route, infectious diseases screened, test results, and primary infectious disease diagnosis for RIM patients seen at GeoSentinel sites. Descriptive statistics were performed.

resultsBetween October 2016 and November 2018, 5,319 RIM patients were evaluated at GeoSentinel sites in 19 countries. Africa was the region of birth for 2,436 patients (46 %), followed by the Americas (1,644, 31 %), and Asia (1,098, 21 %). Tuberculosis (TB) was the most common infection screened and reported as positive (853/2,273, 38 % positive by any method). TB, strongyloidiasis, and hepatitis B surface antigen positivity were observed across all migration administrative categories and regions of birth. Chagas disease was reported only among RIM patients from the Americas (393/394, 100 %) and schistosomiasis predominantly in those from Africa (480/510, 94 %). TB infection (694/5,319, 13 %) and Chagas disease (524/5,319, 10 %) were the leading primary infectious disease diagnoses.

conclusionsSeveral infections of long latency (e.g. TB, hepatitis B, and strongyloidiasis) with potential for long-term sequelae were seen among RIM patients across all migration administrative categories and regions of origin. Obtaining detailed epidemiologic information from RIM patients is critical to optimize detection of diseases of individual and public health importance, particularly those with long latency periods.

Indexed as

Chagas DiseaseEmigrants and ImmigrantsHepatitis BRefugeesStrongyloidiasisTransients and MigrantsTuberculosisHumansChagas diseasehepatitis BInfectious diseasesmigrationrefugee healthschistosomiasisscreeningsentinel surveillancestrongyloidiasistuberculosis

Identifiers

PMID37852594
PMCPMC10760402
OpenAlexW4387710938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.